139 related articles for article (PubMed ID: 38423654)
1. Effect of Ferroptosis Inducers and Inhibitors on Cell Proliferation in Acute Leukemia.
Kumada H; Itoh M; Tohda S
Anticancer Res; 2024 Mar; 44(3):1003-1010. PubMed ID: 38423654
[TBL] [Abstract][Full Text] [Related]
2. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia.
Feng S; Yuan Y; Lin Z; Li M; Ye D; Shi L; Li D; Zhao M; Meng C; He X; Wu S; Xiong F; Ye S; Yang J; Zhuang H; Hong L; Gao S
Exp Hematol Oncol; 2024 Feb; 13(1):19. PubMed ID: 38378601
[TBL] [Abstract][Full Text] [Related]
3. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
[TBL] [Abstract][Full Text] [Related]
4. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
[TBL] [Abstract][Full Text] [Related]
5. RSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death.
Dächert J; Schoeneberger H; Rohde K; Fulda S
Oncotarget; 2016 Sep; 7(39):63779-63792. PubMed ID: 27588473
[TBL] [Abstract][Full Text] [Related]
6. Slowly progressive cell death induced by GPx4-deficiency occurs via MEK1/ERK2 activation as a downstream signal after iron-independent lipid peroxidation.
Tsuruta K; Matsuoka M; Harada S; Enomoto A; Kumagai T; Yasuda S; Koumura T; Yamada KI; Imai H
J Clin Biochem Nutr; 2024 Mar; 74(2):97-107. PubMed ID: 38510679
[TBL] [Abstract][Full Text] [Related]
7. [Effect and Involved Mechanism of RSL3-induced Ferroptosis in Acute Leukemia Cells MOLM13 and Drug-resistant Cell Lines].
Cheng L; Jin X; Lu WY; Sun R; Cao YQ; Wei YX; Wang LQ; He XY; Yuan T; Meng JX; Zhao MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1109-1118. PubMed ID: 34362489
[TBL] [Abstract][Full Text] [Related]
8. Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers.
Kojima Y; Tanaka M; Sasaki M; Ozeki K; Shimura T; Kubota E; Kataoka H
J Gastroenterol; 2024 Feb; 59(2):81-94. PubMed ID: 37947872
[TBL] [Abstract][Full Text] [Related]
9. Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death.
Probst L; Dächert J; Schenk B; Fulda S
Biochem Pharmacol; 2017 Sep; 140():41-52. PubMed ID: 28595877
[TBL] [Abstract][Full Text] [Related]
10. Effects of MYC Inhibitors on the Growth of Acute Leukaemia Cells.
Noguchi K; Itoh M; Ito C; Tohda S
Anticancer Res; 2023 Jul; 43(7):3023-3028. PubMed ID: 37351975
[TBL] [Abstract][Full Text] [Related]
11. Renin-Angiotensin System Inhibitors Suppress the Growth of Leukemia Cells.
Itoh M; Sasaki S; Tohda S
Anticancer Res; 2024 Mar; 44(3):1183-1192. PubMed ID: 38423665
[TBL] [Abstract][Full Text] [Related]
12. GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis.
Kim JW; Min DW; Kim D; Kim J; Kim MJ; Lim H; Lee JY
Sci Rep; 2023 May; 13(1):8872. PubMed ID: 37258589
[TBL] [Abstract][Full Text] [Related]
13. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1.
Cheff DM; Huang C; Scholzen KC; Gencheva R; Ronzetti MH; Cheng Q; Hall MD; Arnér ESJ
Redox Biol; 2023 Jun; 62():102703. PubMed ID: 37087975
[TBL] [Abstract][Full Text] [Related]
14. APR-246 induces early cell death by ferroptosis in acute myeloid leukemia.
Birsen R; Larrue C; Decroocq J; Johnson N; Guiraud N; Gotanegre M; Cantero-Aguilar L; Grignano E; Huynh T; Fontenay M; Kosmider O; Mayeux P; Chapuis N; Sarry JE; Tamburini J; Bouscary D
Haematologica; 2022 Feb; 107(2):403-416. PubMed ID: 33406814
[TBL] [Abstract][Full Text] [Related]
15. [MACC1 knockdown enhances RSL3-induced ferroptosis in human colorectal cancer cells by inhibiting GPX4 expression].
Sun S; Huang X; Li G; Zhang C; Lu Z; Zhang W; Li Z; Yang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):173-178. PubMed ID: 38293989
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of ferroptosis and their involvement in brain diseases.
Costa I; Barbosa DJ; Benfeito S; Silva V; Chavarria D; Borges F; Remião F; Silva R
Pharmacol Ther; 2023 Apr; 244():108373. PubMed ID: 36894028
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal Cancer Cells: Implications in Therapy.
Sinha BK; Bortner CD; Jarmusch AK; Tokar EJ; Murphy C; Wu X; Winter H; Cannon RE
Cells; 2023 Jun; 12(12):. PubMed ID: 37371096
[TBL] [Abstract][Full Text] [Related]
18. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents.
Yu Y; Xie Y; Cao L; Yang L; Yang M; Lotze MT; Zeh HJ; Kang R; Tang D
Mol Cell Oncol; 2015; 2(4):e1054549. PubMed ID: 27308510
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide metabolism is linked to cysteine availability.
Allen AE; Sun Y; Wei F; Reid MA; Locasale JW
J Biol Chem; 2023 Apr; 299(4):103039. PubMed ID: 36803962
[TBL] [Abstract][Full Text] [Related]
20. Circadian clock protein Bmal1 accelerates acute myeloid leukemia by inhibiting ferroptosis through the EBF3/ALOX15 axis.
Wang D; Wang F; Zhang H; Chen P; Yang M
Cancer Sci; 2023 Aug; 114(8):3446-3460. PubMed ID: 37271497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
